414 related articles for article (PubMed ID: 29692255)
21. European Dermatology Forum S1-guideline on the diagnosis and treatment of sclerosing diseases of the skin, Part 1: localized scleroderma, systemic sclerosis and overlap syndromes.
Knobler R; Moinzadeh P; Hunzelmann N; Kreuter A; Cozzio A; Mouthon L; Cutolo M; Rongioletti F; Denton CP; Rudnicka L; Frasin LA; Smith V; Gabrielli A; Aberer E; Bagot M; Bali G; Bouaziz J; Braae Olesen A; Foeldvari I; Frances C; Jalili A; Just U; Kähäri V; Kárpáti S; Kofoed K; Krasowska D; Olszewska M; Orteu C; Panelius J; Parodi A; Petit A; Quaglino P; Ranki A; Sanchez Schmidt JM; Seneschal J; Skrok A; Sticherling M; Sunderkötter C; Taieb A; Tanew A; Wolf P; Worm M; Wutte NJ; Krieg T
J Eur Acad Dermatol Venereol; 2017 Sep; 31(9):1401-1424. PubMed ID: 28792092
[TBL] [Abstract][Full Text] [Related]
22. Localized scleroderma: a series of 52 patients.
Toledano C; Rabhi S; Kettaneh A; Fabre B; Fardet L; Tiev KP; Cabane J
Eur J Intern Med; 2009 May; 20(3):331-6. PubMed ID: 19393504
[TBL] [Abstract][Full Text] [Related]
23. Scleroderma in children.
Zulian F
Best Pract Res Clin Rheumatol; 2017 Aug; 31(4):576-595. PubMed ID: 29773274
[TBL] [Abstract][Full Text] [Related]
24. Scleroderma and fasciitis in children.
Black CM
Curr Opin Rheumatol; 1995 Sep; 7(5):442-8. PubMed ID: 8519619
[TBL] [Abstract][Full Text] [Related]
25. Cutaneous and subcutaneous inflammatory sclerosis syndromes.
Doyle JA; Connolly SM; Winkelmann RK
Arch Dermatol; 1982 Nov; 118(11):886-90. PubMed ID: 7138043
[TBL] [Abstract][Full Text] [Related]
26. Scleroderma in children: emerging management issues.
Panda S
Indian J Dermatol Venereol Leprol; 2010; 76(4):348-56. PubMed ID: 20657114
[TBL] [Abstract][Full Text] [Related]
27. Localized severe scleroderma: a retrospective study of 26 pediatric patients.
Beltramelli M; Vercellesi P; Frasin A; Gelmetti C; Corona F
Pediatr Dermatol; 2010; 27(5):476-80. PubMed ID: 20796242
[TBL] [Abstract][Full Text] [Related]
28. Scleroderma of the Hand: Evaluation and Treatment.
Beldner S; Rabinovich RV; Polatsch DB
J Am Acad Orthop Surg; 2020 Aug; 28(16):e686-e695. PubMed ID: 32769717
[TBL] [Abstract][Full Text] [Related]
29. Development of consensus treatment plans for juvenile localized scleroderma: a roadmap toward comparative effectiveness studies in juvenile localized scleroderma.
Li SC; Torok KS; Pope E; Dedeoglu F; Hong S; Jacobe HT; Rabinovich CE; Laxer RM; Higgins GC; Ferguson PJ; Lasky A; Baszis K; Becker M; Campillo S; Cartwright V; Cidon M; Inman CJ; Jerath R; O'Neil KM; Vora S; Zeft A; Wallace CA; Ilowite NT; Fuhlbrigge RC;
Arthritis Care Res (Hoboken); 2012 Aug; 64(8):1175-85. PubMed ID: 22505322
[TBL] [Abstract][Full Text] [Related]
30. Pediatric scleroderma.
Emery H
Semin Cutan Med Surg; 1998 Mar; 17(1):41-7. PubMed ID: 9512106
[TBL] [Abstract][Full Text] [Related]
31. [How to recognize scleroderma].
Francès C; Ayoub N; Barete S
Rev Prat; 2002 Nov; 52(17):1884-90. PubMed ID: 12532864
[TBL] [Abstract][Full Text] [Related]
32. [Juvenile localized scleroderma].
Strauss T; Günther C; Brück N
Dermatologie (Heidelb); 2024 Mar; 75(3):208-213. PubMed ID: 38240812
[TBL] [Abstract][Full Text] [Related]
33. Diagnostic criteria, severity classification and guidelines of localized scleroderma.
Asano Y; Fujimoto M; Ishikawa O; Sato S; Jinnin M; Takehara K; Hasegawa M; Yamamoto T; Ihn H
J Dermatol; 2018 Jul; 45(7):755-780. PubMed ID: 29687475
[TBL] [Abstract][Full Text] [Related]
34. Juvenile scleroderma: experience in one institution.
Lo CY; Shyur SD; Chu SH; Huang LH; Kao YH; Lei WT; Cheng CH; Lee KH; Chen CK; Liu LC
Asian Pac J Allergy Immunol; 2010 Dec; 28(4):279-86. PubMed ID: 21337913
[TBL] [Abstract][Full Text] [Related]
35. Localized scleroderma.
Kreuter A
Dermatol Ther; 2012; 25(2):135-47. PubMed ID: 22741933
[TBL] [Abstract][Full Text] [Related]
36. Epidemiology and pathogenesis of scleroderma.
Chen K; See A; Shumack S
Australas J Dermatol; 2003 Feb; 44(1):1-7; quiz 8-9. PubMed ID: 12581091
[TBL] [Abstract][Full Text] [Related]
37. Clinical Characteristics and Factors Associated With Disability and Impaired Quality of Life in Children With Juvenile Systemic Sclerosis: Results From the Childhood Arthritis and Rheumatology Research Alliance Legacy Registry.
Stevens BE; Torok KS; Li SC; Hershey N; Curran M; Higgins GC; Moore KF; Egla Rabinovich C; Dodson S; Stevens AM;
Arthritis Care Res (Hoboken); 2018 Dec; 70(12):1806-1813. PubMed ID: 29457372
[TBL] [Abstract][Full Text] [Related]
38. [Scleroderma in a hospital setting in Togo].
Pitche P; Amanga Y; Koumouvi K; Oniankitan O; Mijiyawa M; Tchangaï-Walla K
Med Trop (Mars); 1998; 58(1):65-8. PubMed ID: 9718559
[TBL] [Abstract][Full Text] [Related]
39. Treatment in Juvenile Scleroderma.
Zulian F; Tirelli F
Curr Rheumatol Rep; 2020 Jun; 22(8):45. PubMed ID: 32591919
[TBL] [Abstract][Full Text] [Related]
40. [Systemic sclerosis and scleroderma circumscripta--disturbances of selected serum parameters which are responsible for vascular changes and CD34 expression in involved skin].
Dziankowska-Bartkowiak B; Zebrowska A; Wagrowska-Danielewicz M; Kobos J; Waszczykowska E
Przegl Lek; 2009; 66(12):1040-5. PubMed ID: 20514902
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
